J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft

Johnson & Johnson’s (JNJ) first-quarter 2024 earnings came in at $2.71 per share, which beat the Zacks Consensus Estimate of $2.64. Earnings rose 12.4% from the year-ago period.Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported first-quarter earnings of $2.20 per share against a loss of 19 cents in the year-ago quarter.Sales of this drug and medical devices giant came in at $21.38 billion, missing the Zacks Consensus Estimate of $21.40 billion ...